PORTENT aims to advance promising PoC technologies through: technology development, human validation, user and developer training and rotations, and commercialization. The center is to be enabled by a one-of-a-kind international network of clinical, training, and device development facilities and unique worldwide expertise in point-of-care diagnostics, their application and commercialization. This includes our integrated core clinical and validation facilities across four continents – North America (United States – New York City), Africa (Uganda), South America (Ecuador), and Asia (India), enabling the validation of technologies on a global range of populations and with a unique set of users.
The PORTENT Center seeks to address the clinical needs expressed above through the development and validation of point-of-care technologies with the key metric of having the potential for the largest global impact. Our clinical scope, covering Nutrition, Infection, and Cancer, is large to allow us to focus on the potential for broad impact.
